Proton therapy in the management of non-Hodgkin lymphoma.

about

Radiotherapy for Non-Hodgkin's lymphoma: still standard practice and not an outdated treatment option

P2860

Q28079951-A58145C3-E385-4B1D-A71E-B363E3B6EABF

P2860

Proton therapy in the management of non-Hodgkin lymphoma.

Item

http://www.wikidata.org/entity/Q36518955

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Proton therapy in the management of non-Hodgkin lymphoma.

@ast

Proton therapy in the management of non-Hodgkin lymphoma.

@en

type

Item

label

Proton therapy in the management of non-Hodgkin lymphoma.

@ast

Proton therapy in the management of non-Hodgkin lymphoma.

@en

prefLabel

Proton therapy in the management of non-Hodgkin lymphoma.

@ast

Proton therapy in the management of non-Hodgkin lymphoma.

@en

P1476

Proton therapy in the management of non-Hodgkin lymphoma

@en

P2093

James Lynch

http://www.w3.org/2001/XMLSchema#string

Stella Flampouri

http://www.w3.org/2001/XMLSchema#string

Suzanne Sachsman

http://www.w3.org/2001/XMLSchema#string

Zuofeng Li

http://www.w3.org/2001/XMLSchema#string

P2860

Curative radiotherapy for primary orbital lymphoma.

Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study.

Effective dose reduction to cardiac structures using protons compared with 3DCRT and IMRT in mediastinal Hodgkin lymphoma.

Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).

Involved-node proton therapy in combined modality therapy for Hodgkin lymphoma: results of a phase 2 study.

Long-term outcomes and patterns of failure in orbital lymphoma treated with primary radiotherapy.

Dosimetric evaluation and treatment outcome of intensity modulated radiation therapy after doxorubicin-based chemotherapy for primary mediastinal large B-cell lymphoma.

High-dose and extended-field intensity modulated radiation therapy for early-stage NK/T-cell lymphoma of Waldeyer's ring: dosimetric analysis and clinical outcome.

Incidence of second malignancies among patients treated with proton versus photon radiation.

P304

2608-2612

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2015.1014364

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Nancy P Mendenhall

Bradford S Hoppe

P577

2015-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272191727

http://www.w3.org/2001/XMLSchema#string

P698

25669925

http://www.w3.org/2001/XMLSchema#string

P932

4732409

http://www.w3.org/2001/XMLSchema#string

Proton therapy in the management of non-Hodgkin lymphoma.

about

P2860

P2860

Proton therapy in the management of non-Hodgkin lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932